UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BSX — Boston Scientific Corp
CIK 861177
NEW YORK, NY
Position in BSX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$558,744,402
-$289,244,723 QoQ
Shares Held
13,091,481
-3.1% QoQ
Ownership
0.903%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#25
of 1,468 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,740,663,804 across 61 Medical Devices names. BSX ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
12,835,753 | $1,164,716,222 | |
| 2 | SYK |
Stryker Corp
|
2,689,376 | $846,723,135 | |
| 3 | DXCM |
Dexcom Inc
|
11,261,876 | $758,487,343 | |
| 4 | BSX |
Boston Scientific Corp
This page
|
13,091,481 | $558,744,402 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,488,643 | $496,502,640 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
2,541,393 | $162,674,562 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
1,457,553 | $125,480,733 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
418,884 | $122,988,525 |
All Filings in BSX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $558,744,402 | 13,091,481 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $847,989,125 | 13,513,771 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,042,838,846 | 10,936,957 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,071,819,720 | 10,978,385 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,369,485,013 | 12,750,070 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,139,938,141 | 11,299,942 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $968,171,807 | 10,839,362 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $765,085,699 | 9,129,901 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $731,391,535 | 9,497,358 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $501,578,565 | 7,323,384 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $459,284,721 | 7,944,728 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $405,399,084 | 7,678,013 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $391,416,383 | 7,236,391 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $362,036,636 | 7,236,391 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $377,225,055 | 8,152,692 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $216,780,015 | 5,597,212 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $210,564,051 | 5,649,693 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $251,015,519 | 5,667,544 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $241,879,416 | 5,693,960 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $275,887,673 | 6,358,324 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $287,307,940 | 6,719,082 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $316,916,970 | 8,199,663 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $278,486,492 | 7,746,495 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $266,154,653 | 6,965,576 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $236,438,530 | 6,734,222 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $173,924,323 | 5,330,197 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||